Amaryllidaceae Alkaloids of Different Structural Types from Narcissus L. cv. Professor Einstein and Their Cytotoxic Activity

. 2020 Jan 22 ; 9 (2) : . [epub] 20200122

Status PubMed-not-MEDLINE Jazyk angličtina Země Švýcarsko Médium electronic

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/pmid31978967

Grantová podpora
SVV UK 260 412; 260 401; Progres/UK Q40 and Q42 Univerzita Karlova
No. 00179906 Universitz Hospital, Hradec Králové, Czech Republic
Long-term development plan Faculty of Military Health Sciences
Reg. No. CZ.02.1.01/0.0/0.0/18_069/0010046 European Union

In this detailed phytochemical study of Narcissus cv. Professor Einstein, we isolated 23 previously known Amaryllidaceae alkaloids (1-23) of several structural types and one previously undescribed alkaloid, 7-oxonorpluviine. The chemical structures were identified by various spectroscopic methods (GC-MS, LC-MS, 1D, and 2D NMR spectroscopy) and were compared with literature data. Alkaloids which had not previously been isolated and studied for cytotoxicity before and which were obtained in sufficient amounts were assayed for their cytotoxic activity on a panel of human cancer cell lines of different histotype. Above that, MRC-5 human fibroblasts were used as a control noncancerous cell line to determine the general toxicity of the tested compounds. The cytotoxicity of the tested alkaloids was evaluated using the WST-1 metabolic activity assay. The growth of all studied cancer cell lines was inhibited by pancracine (montanine-type alkaloid), with IC50 values which were in the range of 2.20 to 5.15 µM.

Zobrazit více v PubMed

Ingrassia L., Lefranc F., Mathieu V., Darro F., Kiss R. Amaryllidaceae isocarbostyril alkaloids and their derivatives as promising antitumor agents. Transl. Oncol. 2008;1:1–13. doi: 10.1593/tlo.08100. PubMed DOI PMC

Havelek R., Muthna D., Tomsik P., Kralovec K., Seifrtova M., Cahlikova L., Hostalkova A., Safratova M., Perwein M., Cermakova E., et al. Anticancer potential of Amaryllidaceae alkaloids evaluated by screening with a panel of human cells, real-time cellular analysis and Ehrlich tumor-bearing mice. Chem. Biol. Interact. 2017;275:121–132. doi: 10.1016/j.cbi.2017.07.018. PubMed DOI

Nair J.J., van Standen J. Cytotoxicity studies of lycorine alkaloids of the Amaryllidaceae. Nat. Prod. Commun. 2014;9:1193–1210. doi: 10.1177/1934578X1400900834. PubMed DOI

Cho N., Du Y., Valenciano A.L., Fernandez-Murga M.L., Goetz M., Clement J., Cassera M.B., Kingston D.G.I. Antiplasmodial alkaloids from bulbs of Amaryllis belladonna Steud. Bioor. Med. Chem. Lett. 2018;28:40–42. doi: 10.1016/j.bmcl.2017.11.021. PubMed DOI PMC

Zhan G., Zhou J., Liu R., Liu T., Guo G., Wang J., Xiang M., Xue Y., Luo Z., Zhang Y., et al. Galanthamine, plicamine, and secoplicamine alkaloids from Zephyranthes candida and their anti-acetylcholinesterase and antiinflammatory activities. J. Nat. Prod. 2016;79:760–766. doi: 10.1021/acs.jnatprod.5b00681. PubMed DOI

Locarek M., Novakova J., Kloucek P., Hostalkova A., Kokoska L., Gabrlova L., Safratova M., Opletal L., Cahlikova L. Antifugal and antibacterial activity of extracts and alkaloids of selected Amaryllidaceae plant species. Nat. Prod. Commun. 2015;10:1537–1540. PubMed

Hulcova D., Maříkova J., Korabecny J., Hostalkova A., Jun D., Kunes J., Chlebek J., Opletal L., De Simone A., Novakova L., et al. Amaryllidaceae alkaloids from Narcissus pseudonarcissus L. cv. Dutch Master as potential drugs in treatment of Alzheimer’s disease. Phytochemistry. 2019;165:112055. doi: 10.1016/j.phytochem.2019.112055. PubMed DOI

Castillo-Ordonez W.O., Tamarozzi E.R., da Silva G.M., Aristizabal-Pachon A.F., Sakamoto-Hojo E.T., Takahashi C.S., Giuliatti S. Exploration of the acetylcholinesterase inhibitory activity of some alkaloids from Amaryllidaceae family by molecular docking in silico. Neurochem. Res. 2017;42:2826–2830. doi: 10.1007/s11064-017-2295-8. PubMed DOI

Jin Z. Amaryllidaceae and Sceletium alkaloids. Nat. Prod. Rep. 2007;24:886–905. doi: 10.1039/b502163b. PubMed DOI

Safratova M., Hostalkova A., Hulcova D., Breiterova K., Hrabcova V., Machado M., Fontinha D., Prudêncio M., Kunes J., Chlebek J., et al. Alkaloids from Narcissus poeticus cv. Pink Parasol of various structural types and their biological activity. Arch. Pharm. Res. 2018;41:208–218. doi: 10.1007/s12272-017-1000-4. PubMed DOI

Maelicke A., Samochocki M., Jostock R., Fehrenbacher A., Ludwig J., Albuquerque E.X., Zerlin M. Allosteric sensitization of nicotinic receptors by galanthamine, a new treatment strategy for Alzheimer’s disease. Biol. Psychiatry. 2001;49:279–288. doi: 10.1016/S0006-3223(00)01109-4. PubMed DOI

Govindaraju K., Ingels A., Hasan M.N., Sun D., Mathieu V., Masi M., Evidente A., Kornienko A. Synthetic analogues of the montanine-type alkaloids with activity against apoptosis-resistant cancer cells. Bioorg. Med. Chem. Lett. 2018;28:589–593. doi: 10.1016/j.bmcl.2018.01.041. PubMed DOI PMC

Evidente A., Kireev A.S., Jenkins A.R., Romero A.E., Steelant W.F., Van Slambrouck S., Kornienko A. Biological evaluation of structurally diverse Amaryllidaceae alkaloids and their synthetic derivatives: Discovery of novel leads for anticancer drug design. Planta Med. 2009;75:501–507. doi: 10.1055/s-0029-1185340. PubMed DOI PMC

Ingrassia L., Lefranc F., Dewelle J., Pottier L., Mathieu V., Spiegl-Kreinecker S., Sauvage S., El Yazidi M., Dehoux M., Berger W., et al. Structure-activity relationship analysis of novel derivatives of narciclasine (an Amaryllidaceae isocarbostyril derivative) as potential anticancer agents. J. Med. Chem. 2009;52:1100–1114. doi: 10.1021/jm8013585. PubMed DOI

Havelek R., Seifrtova M., Kralovec K., Bruckova L., Cahlikova L., Dalecka M., Vavrova J., Rezacova M., Opletal L., Bilkova Z. The effect of Amaryllidaceae alkaloids haemanthamine and haemanthidine on cell cycle progression and apoptosis in p53-negative human leukemic Jurkat cells. Phytomedicine. 2014;21:479–490. doi: 10.1016/j.phymed.2013.09.005. PubMed DOI

Li L., Zhang Z., Yang Q., Ning M. Lycorine inhibited the cell growth of non-small cell lung cancer by modulating the miR-186/CDK1 axis. Life Sci. 2019;231:116528. doi: 10.1016/j.lfs.2019.06.003. PubMed DOI

Breiterova K., Locarek M., Kohelova E., Talackova M., Hulcova D., Opletal L., Cahlikova L. Daffodils as potential crops of biologically-active compounds: Assessment of 40 ornamental taxa for their alkaloid profile and cholinesterases inhibition activity. Nat. Prod. Commun. 2018;13:419–422. doi: 10.1177/1934578X1801300410. DOI

Kornienko A., Evidente A. Chemistry, biology, and medicinal potential of narciclasine and its congeners. Chem. Rev. 2008;108:1982–2014. doi: 10.1021/cr078198u. PubMed DOI PMC

Hartwell J.L. Plants used against cancer. A survey. Lloydia. 1967;30:379–436.

Kington S. The International Daffodil Register and Classified List. Royal Horticultural Society; London, UK: 2008.

Pettit G.R., Tan R., Bao G.-H., Melody N., Doubek D.L., Gao S., Chapuis J.-C., Williams L. Antineoplastic agents. 587. Isolation and structure of 3-epipancratistatin from Narcissus cv. Ice Follies. J. Nat. Prod. 2012;75:771–773. doi: 10.1021/np200862y. PubMed DOI PMC

Pigni N.B., Ríos-Ruiz S., Martínez-Francés V., Nair J.J., Viladomat F., Codina C., Bastida J. Alkaloids from Narcissus serotinus. J. Nat. Prod. 2012;75:1643–1647. doi: 10.1021/np3003595. PubMed DOI

Huang S., Zhang Y., He H., Li S., Tang G., Chen D., Cao M., Di Y., Hao X.J. A new Amaryllidaceae alkaloid from bulbs of Lycoris radiata. Chin. J. Nat. Med. 2013;11:406–410. doi: 10.3724/SP.J.1009.2013.00406. PubMed DOI PMC

Cowden C.J., Banwell M.G., Ho I.C.S. Synthesis of putative structure of 5,6-dihydrobicolorin. J. Nat. Prod. 1994;57:1746–1750. doi: 10.1021/np50114a023. DOI

Lamoral-Theys D., Andolfi A., Van Goietsenoven G., Cimmino A., Le Calvé B., Wauthoz N., Mégalizzi V., Gras T., Bruyere C., Dubois J., et al. Lycorine, the main phenanthridine Amaryllidaceae alkaloid, exhibits significant antitumor activity in cancer cells that display resistance to proapoptotic stimuli: An investigation of structure-activity relationship and mechanistic insight. J. Med. Chem. 2009;52:6244–6625. doi: 10.1021/jm901031h. PubMed DOI PMC

Chen J.-Q., Xie J.-H., Bao D.-H., Liu S., Zhou Q.-L. Total synthesis of (−)-galanthamine and (−)-lycoramine via catalytic asymmetric hydrogenation and intramolecular reductive Heck cyclization. Org. Lett. 2012;14:2714–2717. doi: 10.1021/ol300913g. PubMed DOI

Jegorov A., Buchta M., Sedmera P., Kuzma M., Havlicek V. Accurate product ion mass spectra of galanthamine derivatives. J. Mass. Spectrom. 2006;41:544–548. doi: 10.1002/jms.1015. PubMed DOI

Lee T.B.K., Goehring K.E., Ma Z. One-Step conversion of galanthamine to lycoraminone: A novel hydride-transfer reaction. J. Org. Chem. 1998;63:4535–4538. doi: 10.1021/jo980271g. DOI

Berkov S., Reyes-Chilpa R., Codina C., Viladomat F., Bastida J. Revised NMR data for incartine: An alkaloid from Galanthus elwesii. Molecules. 2007;12:1430–1435. doi: 10.3390/12071430. PubMed DOI PMC

Berkov S., Bastida J., Sidjimova B., Viladomat F., Codina C. Phytochemical differentiation of Galanthus nivalis and Galanthus elwesii (Amaryllidaceae): A case study. Biochem. Syst. Ecol. 2008;36:638–645. doi: 10.1016/j.bse.2008.04.002. DOI

Bastida J., Viladomat F., Bergonon S., Fernandez J.M., Codina C., Rubiralta M., Quirion J.-C. Alkaloids from Narcissus leonensis. Phytochemistry. 1993;34:1656–1658. doi: 10.1016/S0031-9422(00)90869-0. DOI

Bastida J., Lavilla R., Viladomat F. The Alkaloids: Chemical and biological aspects of Narcissus alkaloids. In: Cordell G.A., editor. The Alkaloids: Chemistry and Biology. Volume 63. Elsevier; Amsterdam, The Netherlands: 1998. pp. 87–179. PubMed PMC

Jeffs P.W., Abou-Donia A., Campau D. Structures of 9-O-demethylhomolycorine and 5α-hydroxyhomolycorine. alkaloids of Crinum defixum, C. scabrum, and C. latifolium. Assignment of aromatic substitution patterns from 1H-coupled 13C spectra. J. Org. Chem. 1985;50:1732–1737. doi: 10.1021/jo00210a031. DOI

Ghosal S., Ashutosh Razdan S. (+)-Epimaritidine, an alkaloid from Zephyranthes rosea. Phytochemistry. 1985;24:635–637. doi: 10.1016/S0031-9422(00)80796-7. DOI

Berkov S., Sidjimove B., Evstatieva L., Popov S. Intraspecific variability in the alkaloid metabolism of Galanthus elwesii. Phytochemistry. 2004;65:579–586. doi: 10.1016/j.phytochem.2003.12.013. PubMed DOI

Pham L.H., Gründemann E., Wagner J., Bartoszek M., Döpke W. Two novel Amaryllidaceae alkaloids from Hippeastrum equestre Herb.: 3-O-demethyltazettine and egonine. Phytochemistry. 1999;51:327–332. doi: 10.1016/S0031-9422(98)00743-2. DOI

Via J., Arriortura M.I., Ochando L.E., Reventos M.M., Amigo J.M., Bastida J. Structure of eugenine, an alkaloid from Narcissus eugeniae. Acta Cryst. C. 1989;45:2020–2022. doi: 10.1107/S0108270189007973. DOI

Berkov S., Romani S., Herrera M., Viladomat F., Codina C., Momekov G., Ionkova I., Bastida J. Antiproliferative alkaloids from Crinum zeylanicum. Phytother. Res. 2011;25:1686–1692. doi: 10.1002/ptr.3468. PubMed DOI

Bastida J., Llabrés J.M., Viladomat F., Codina C., Rubiralta M., Feliz M. 9-O-Demethylmaritidine: A new alkaloid from Narcissus radinganorum. Planta Med. 1988;54:524–526. doi: 10.1055/s-2006-962537. PubMed DOI

Bao X., Cao Y.-X., Chu W.-D., Qu H., Du J.-Y., Zhao X.-H., Ma X.-Y., Wang C.-T., Fan C.-A. Bioinspired total synthesis of montanine-type Amaryllidaceae alkaloids. Angew. Chem. Int. Edit. 2013;52:14167–14172. doi: 10.1002/anie.201307324. PubMed DOI

Farinon M., Clarimundo V.S., Pedrazza G.P., Gulko P.S., Zuanazzi J.A., Xavier R.M., de Oliveira P.G. Disease modifying anti-rheumatic activity of the alkaloid montanine on experimental arthritis and fibroblast-like synoviocytes. Eur. J. Pharmacol. 2017;15:180–187. doi: 10.1016/j.ejphar.2017.02.013. PubMed DOI

Masi M., van Slambrouck S., Gunawardana S., van Rensburg M.J., James P.C., Mochel J.G., Heliso P.S., Albalawi A.S., Cimmino A., van Otterlo W.A.L., et al. Alkaloids isolated from Haemanthus humilis Jacq., an indigenous South African Amaryllidaceae: Anticancer activity of coccinine and montanine. S. Afr. J. Bot. 2019;126:277–281. doi: 10.1016/j.sajb.2019.01.036. DOI

Havelek R., Siman P., Cmielova J., Stoklasova A., Vavrova J., Vinklarek J., Knizek J., Rezacova M. Differences in vanadocene dichloride and cisplatin effect on MOLT-4 leukemia and human peripheral blood mononuclear cells. Med. Chem. 2012;8:615–621. doi: 10.2174/157340612801216364. PubMed DOI

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...